Skip to main content
. 2018 Jan 22;9(3):201–207. doi: 10.1007/s13340-018-0344-4

Table 3.

Correlation between the reduction in the duration of hypoglycemia or in HbA1c level at 12 months after the switch to SAP therapy and other parameters

Parameter Reduction in duration of hypoglycemia Reduction in HbA1c level
Age P = 0.44
r = 0.19
P < 0.05
r = − 0.49
Baseline HbA1c level P = 0.19
r = 0.32
P = 0.09
r = 0.41
Frequency of self-monitoring of blood glucose (SMBG) P = 0.20
r = − 0.31
P = 0.35
r = − 0.23
Sensor usage P = 0.69
r = − 0.10
P = 0.53
r = − 0.16
Frequency of hypoglycemic alarms P = 0.68
r = − 0.11
P = 0.43
r = 0.20
Frequency of hyperglycemic alarms P = 0.91
r = − 0.03
P = 0.05
r = 0.47
Bolus frequency P = 0.27
r = − 0.28
P = 0.46
r = 0.19
Frequency of correction bolus P = 0.38
r = − 0.22
P = 0.53
r = − 0.16